GlassScriptPhysician profile
Allison C Salk
NPI 1043871676
$241.36
in general payments reported to CMS, 2019-2025
9 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $12.49 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $228.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $47.65 | 2025 | Wegovy |
| Astellas Pharma US INC | $42.79 | 2025 | Veozah |
| Abbvie INC. | $28.85 | 2025 | |
| Bluewind Medical | $26.59 | 2025 | Revi |
| Hologic Sales and Service, LLC | $23.61 | 2025 | Myosure Tissue Removal Device |
| Organon LLC | $22.39 | 2025 | Jada System |
| Coopersurgical, INC. | $19.86 | 2025 | Paragard T 380a |
| Biogen, INC. | $17.13 | 2025 | Zurzuvae |
| Boston Scientific Corporation | $12.49 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Allison Salk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.